Associated Papers
[Role of ABC Transporters in Cancer Development and Malignant Alteration].
Wada M
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 2022
Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy.
Choi JR et al.
Cancer Research and Treatment, 2015
P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations.
Cascorbi I
Handbook of Experimental Pharmacology, 2011
ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.
Balcerczak E et al.
International Journal of Colorectal Disease, 2010
ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
Panczyk M et al.
International Journal of Colorectal Disease, 2009
Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia.
Hattori H et al.
Leukemia Research, 2007
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
Haenisch S et al.
The Pharmacogenomics Journal, 2007
[MDR1 (ABCB1) gene encoding glycoprotein P (P-gp), a member of ABC transporter superfamily: consequences for therapy and progression of neoplastic diseases].
Panczyk M et al.
Postepy Biochemii, 2007
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.
Kurzawski M et al.
European Journal of Clinical Pharmacology, 2005
Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon.
Taniguchi S et al.
Molecular Cancer Therapeutics, 2003
Select a paper to view details